The Greek Phonological Phrase

RECONSTRUCTING THE PROSODIC' domains' of ancient Greek continues to play an important role in classical philology. The syntactic components of the appositive group, as well as its accentual and rhythmic properties, have been analyzed in fine detail, primarily because of the value of metrical bridges in textual criticism. The major phrase-that is, the phonological counterpart of the syntactic clause or simple sentence-has also been the object of study, especially for its importance in defining the domain of the avoidance of hiatus and in the stylistic evolution of enjambement. But little or no progress has been made in reconstructing the accent and rhythm of the minor phonological phrase (hereafter simply the 'phonological phrase'), nor in analyzing its syntactic composition. Almost nothing has been discovered about how the words of even the simplest sentences were joined together into prosodic subunits in ordinary Greek speech. How can we demonstrate that there actually were prosodic domains intermediate between the word or appositive group and the utterance? And if we can, how do we know which sequences of words can make up these phonological phrases and which cannot? Under what circumstances, if any, can a subject be phrased with its Verb? Can a direct object modified by an Adjective be phrased with its Verb? What happens if there is also an indirect object? Is a Prepositional Phrase always a phonological phrase by itself or can it be joined with an adjacent constituent? In addition to discovering its syntactic constituency, we should also like to know what the Greek phonological phrase sounded like; specifically whether, in addition to the temporal demarcation (final lengthening) normally found at the end of phonological phrases, the Greek phonological phrase was also characterized by tonal properties such as the scaling of accentual peaks within the phonological phrase

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

For a decade, The Cancer Genome Atlas (TCGA) program collected clinicopathologic annotation data along with multi-platform molecular profiles of more than 11,000 human tumors across 33 different cancer types. TCGA clinical data contain key features representing the democratized nature of the data collection process. To ensure proper use of this large clinical dataset associated with genomic features, we developed a standardized dataset named the TCGA Pan-Cancer Clinical Data Resource (TCGA-CDR), which includes four major clinical outcome endpoints. In addition to detailing major challenges and statistical limitations encountered during the effort of integrating the acquired clinical data, we present a summary that includes endpoint usage recommendations for each cancer type. These TCGA-CDR findings appear to be consistent with cancer genomics studies independent of the TCGA effort and provide opportunities for investigating cancer biology using clinical correlates at an unprecedented scale. Analysis of clinicopathologic annotations for over 11,000 cancer patients in the TCGA program leads to the generation of TCGA Clinical Data Resource, which provides recommendations of clinical outcome endpoint usage for 33 cancer types

An integrated map of structural variation in 2,504 human genomes

Structural variants are implicated in numerous diseases and make up the majority of varying nucleotides among human genomes. Here we describe an integrated set of eight structural variant classes comprising both balanced and unbalanced variants, which we constructed using short-read DNA sequencing data and statistically phased onto haplotype blocks in 26 human populations. Analysing this set, we identify numerous gene-intersecting structural variants exhibiting population stratification and describe naturally occurring homozygous gene knockouts that suggest the dispensability of a variety of human genes. We demonstrate that structural variants are enriched on haplotypes identified by genome-wide association studies and exhibit enrichment for expression quantitative trait loci. Additionally, we uncover appreciable levels of structural variant complexity at different scales, including genic loci subject to clusters of repeated rearrangement and complex structural variants with multiple breakpoints likely to have formed through individual mutational events. Our catalogue will enhance future studies into structural variant demography, functional impact and disease association. © 2015 Macmillan Publishers Limited. All rights reserved

Integrating sequence and array data to create an improved 1000 Genomes Project haplotype reference panel

A major use of the 1000 Genomes Project (1000GP) data is genotype imputation in genome-wide association studies (GWAS). Here we develop a method to estimate haplotypes from low-coverage sequencing data that can take advantage of single-nucleotide polymorphism (SNP) microarray genotypes on the same samples. First the SNP array data are phased to build a backbone (or 'scaffold') of haplotypes across each chromosome. We then phase the sequence data 'onto' this haplotype scaffold. This approach can take advantage of relatedness between sequenced and non-sequenced samples to improve accuracy. We use this method to create a new 1000GP haplotype reference set for use by the human genetic community. Using a set of validation genotypes at SNP and bi-allelic indels we show that these haplotypes have lower genotype discordance and improved imputation performance into downstream GWAS samples, especially at low-frequency variants. © 2014 Macmillan Publishers Limited. All rights reserved

Driver Fusions and Their Implications in the Development and Treatment of Human Cancers.

Gene fusions represent an important class of somatic alterations in cancer. We systematically investigated fusions in 9,624 tumors across 33 cancer types using multiple fusion calling tools. We identified a total of 25,664 fusions, with a 63% validation rate. Integration of gene expression, copy number, and fusion annotation data revealed that fusions involving oncogenes tend to exhibit increased expression, whereas fusions involving tumor suppressors have the opposite effect. For fusions involving kinases, we found 1,275 with an intact kinase domain, the proportion of which varied significantly across cancer types. Our study suggests that fusions drive the development of 16.5% of cancer cases and function as the sole driver in more than 1% of them. Finally, we identified druggable fusions involving genes such as TMPRSS2, RET, FGFR3, ALK, and ESR1 in 6.0% of cases, and we predicted immunogenic peptides, suggesting that fusions may provide leads for targeted drug and immune therapy

Efecto del glifosato sobre el crecimiento y acumulación de azúcares libres en dos biotipos de lolium perenne de distinta sensibilidad al herbicida

El movimiento sistémico del glifosato está determinado por el transporte de fotoasimilados. A su vez, la capacidad de un destino de consumir los asimilados está condicionada por su actividad metabólica. Pese a su importancia, la relación entre el glifosato y la síntesis de azúcares en hojas fuente ha sido poco abordada. El objetivo del presente trabajo fue evaluar los efectos del glifosato sobre el crecimiento y la acumulación de azúcares libres en dos biotipos de Lolium perenne de baja y alta sensibilidad al herbicida. Se trabajó con clones de ambos tipos de plantas, en macollaje, tratados con 1.440 g e.a. ha-1 de glifosato y sin tratamiento herbicida como controles. Se evaluó periódicamente el efecto del glifosato sobre el rebrote de hojas hasta las 50 horas post-aplicación y sobre los niveles de azúcares libres totales, reductores y no reductores en hojas a 1, 2, 3 y 5 días post-aplicación. A partir de las 25 horas post-aplicación, el glifosato provocó una disminución del crecimiento del 58% en el biotipo susceptible, con una acumulación de azúcares libres superior al 90% con relación al control, desde el primer día post-aplicación en adelante. La inhibición del crecimiento, inducida por el glifosato en plantas susceptibles, no depende de la limitación del traslado de fotoasimilados desde la parte aérea. Por tanto, la acumulación de azúcares libres en hojas podría explicarse por la caída en la tasa de crecimiento. En el biotipo de baja sensibilidad, en el que no se detectó inhibición del crecimiento, estos efectos fueron limitados.The systemic movement of glyphosate is determined by the transport of photoassimilates. In turn, the capacity of a destination to consume assimilates is conditioned by their metabolic activity. Despite its importance, the relationship between the glyphosate and the sugar synthesis from source leaves has been little studied. The aim of this work was to determine the effect of glyphosate on the growth and free sugar accumulation of two Lolium perenne biotypes of low and high glyphosate sensitivity. It was worked with clones of both types, in tillering, sprayed with 1,440 g a.e. ha-1 of glyphosate as treatments and without herbicide as controls. The glyphosate effects on the regrowth of leaves was studied until 50 hours post-application and on total free sugar, reducing free sugar and nonreducing free sugar from leaves to 1, 2, 3 and 5 days post-application were periodically evaluated. From 25 hours after glyphosate application, it caused on the susceptible biotype a growth decrease of 58% and an accumulation of free sugar above 90% compared to controls. In susceptible biotypes, growth inhibition does not depend on a reduced photoassimilate translocation from the overground part. Therefore, the free sugar accumulation in leaves could be explained by the fall in the rate of growth. These effects are limited in the low sensitivity biotype, where growth inhibition has not been detected

Genomic and Functional Approaches to Understanding Cancer Aneuploidy

Aneuploidy, whole chromosome or chromosome arm imbalance, is a near-universal characteristic of human cancers. In 10,522 cancer genomes from The Cancer Genome Atlas, aneuploidy was correlated with TP53 mutation, somatic mutation rate, and expression of proliferation genes. Aneuploidy was anti-correlated with expression of immune signaling genes, due to decreased leukocyte infiltrates in high-aneuploidy samples. Chromosome arm-level alterations show cancer-specific patterns, including loss of chromosome arm 3p in squamous cancers. We applied genome engineering to delete 3p in lung cells, causing decreased proliferation rescued in part by chromosome 3 duplication. This study defines genomic and phenotypic correlates of cancer aneuploidy and provides an experimental approach to study chromosome arm aneuploidy. Analyzing >10,000 human cancers, Taylor et al. show that aneuploidy is correlated with somatic mutation rate, expression of proliferation genes, and decreased leukocyte infiltration. Loss of chromosome arm 3p is common in squamous cancers, but deletion of chromosome 3p reduces cell proliferation in vitro

A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers

We analyzed molecular data on 2,579 tumors from The Cancer Genome Atlas (TCGA) of four gynecological types plus breast. Our aims were to identify shared and unique molecular features, clinically significant subtypes, and potential therapeutic targets. We found 61 somatic copy-number alterations (SCNAs) and 46 significantly mutated genes (SMGs). Eleven SCNAs and 11 SMGs had not been identified in previous TCGA studies of the individual tumor types. We found functionally significant estrogen receptor-regulated long non-coding RNAs (lncRNAs) and gene/lncRNA interaction networks. Pathway analysis identified subtypes with high leukocyte infiltration, raising potential implications for immunotherapy. Using 16 key molecular features, we identified five prognostic subtypes and developed a decision tree that classified patients into the subtypes based on just six features that are assessable in clinical laboratories. By performing molecular analyses of 2,579 TCGA gynecological (OV, UCEC, CESC, and UCS) and breast tumors, Berger et al. identify five prognostic subtypes using 16 key molecular features and propose a decision tree based on six clinically assessable features that classifies patients into the subtypes